Virtual Medicinal Product (VMP) - Bupivacaine 25mg/10ml (0.25%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Bupivacaine 25mg/10ml (0.25%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules Start Date 12-03-2015 End Date
Previous Name Previous Name Bupivacaine 25mg/10ml (0.25%) / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules Start Date 15-10-2007 End Date 11-03-2015
Abbreviated Name Abbreviated Name Bupivacaine 25mg/Adrenaline (base) 50microg/10ml inj amp Start Date 12-03-2015
Previous Abbreviated Name Bupivacaine 25mg/Adrenaline 50microg/10ml inj amp Previous Start Date 15-10-2007 Previous End Date 11-03-2015

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
10
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Epidural, Perineural
Form
Solution for injection
Ontology Form/Route
solutioninjection.epidural, solutioninjection.perineural
Name Basis
Other

Codes

ATC Code
N01BB51
BNF Start Date End Date
Current BNF 15020100 Start Date 04-04-2022 End Date
Previous BNF 15020000 Start Date 24-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
4616011000001101 26-06-2003

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Adrenaline acid tartrate Based on Base Substance Adrenaline 5 microgram 1 ml
Bupivacaine hydrochloride Based on Ingredient Substance 2.5 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 ampoule 4600 Part VIIIA Category C